RxDoctor Payments Data

Shawn Murphy

Neurology · Boston, MANPI 1639160534

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Abbott at 46.8% of the total. Reporting peaked in 2022 at $538 and has fallen 78.7% since, to $115 in 2025.

$820in general payments, 2019–2025

Across 14 payments — averaging $58.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$384
  • Medtronic$169
  • BD$131
  • AstraZeneca$85
  • GSK$34
  • Amgen$17
$5,943,051in research payments, 2019–2025

Across 41 payments — averaging $144,952 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$2.5M
  • Amgen$1.9M
  • Takeda Pharmaceuticals U.S.A., Inc.$541K
  • Janssen Scientific Affairs, LLC$419K
  • Astrazeneca UK Limited$301K
  • Merck$138K
  • plus $208K from 2 others

What the payments were for

  • Food & beverage$820100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott6$384
Medtronic4$169
BD1$131
AstraZeneca1$85
GSK1$34
Amgen1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$820 in reported general payments places this provider in the 55th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →